Financial statements Twoja Farmacja
Balance sheet data of TWOJA FARMACJA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 14 298 188,22 | 13 247 277,83 | 18 005 310,84 | 23 350 389,39 | 26 667 378,51 | 34 019 880,71 |
| A. Fixed assets | 3 777 218,32 | 2 729 266,46 | 3 336 730,52 | 3 684 667,98 | 3 259 176,04 | 4 719 881,71 |
| B. Current assets | 10 520 969,90 | 10 518 011,37 | 14 668 580,32 | 19 665 721,41 | 23 408 202,47 | 29 299 999,00 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 14 298 188,22 | 13 247 277,83 | 18 005 310,84 | 23 350 389,39 | 26 667 378,51 | 34 019 880,71 |
| A. Equity | -24 940 607,67 | -26 577 161,91 | -23 683 382,23 | -21 091 113,83 | -16 723 370,16 | -11 122 828,32 |
| B. Liabilities and provisions for liabilities | 39 238 795,89 | 39 824 439,74 | 41 688 693,07 | 44 441 503,22 | 42 941 051,73 | 45 142 709,03 |
| I. Long-term liabilities | 26 689 996,33 | 27 854 754,76 | 30 108 760,11 | 29 362 705,63 | 28 586 815,13 | 30 296 118,33 |
| II. Short-term liabilities | 7 752 102,42 | 7 625 412,58 | 8 904 331,53 | 12 645 589,11 | 12 403 432,44 | 13 150 413,48 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.